Navigation Links
Bloomberg's health legacy: Urban innovator or meddling nanny?
Date:10/30/2013

(Garrison, NY) As New York City Mayor Michael Bloomberg prepares to leave office, a commentary by a leading bioethicist analyzes his controversial public health policies and concludes that he is an urban innovator who created a new paradigm of public health, "reaching beyond infectious diseases to upstream risk factors in everyday life and the human habitat." The commentary appears in the Hastings Center Report.

Lawrence O. Gostin, University Professor and Founding O'Neill Chair in Global Health Law at Georgetown University Law Center, focuses on Bloomberg's major policies to address the obesity epidemic, improve disease surveillance, increase physical activity, and control tobacco use.

Of the policies on diet and nutrition, Gostin cites as particularly successful the city's limit on trans fatty acids, which "provide no health benefit and are unsafe at any level." In 2006, the city required that any food served to customers (unless in a sealed package) contain less than 0.5 grams of trans fats per serving. "Although the trans fat limit received a warmer public response than other diet-related policies, it still met opposition from restaurants and civil libertarians," Gostin writes. However, the city's limit on trans fats served as a model in the United States and globally, "and low trans fat has now become a widely accepted norm."

Gostin also cites Mr. Bloomberg's tobacco policies, which have dramatically reduced smoking: "Between 2002 and 2011, the rate of smoking fell from 21.5 percent to 41.8 percent among adults and from 17.5 percent to 8.5 percent among youth." Although it is impossible to point to any single tobacco policy, Bloomberg implemented "a range of policies (e.g., taxes, labeling, smoke-free laws, and advertising restrictions) that worked in combination over time to de-normalize smoking."

Gostin explains why, despite the label of "Nanny Bloomberg," the mayor's controversial soda portion limit makes sense: "The mayor relied on science to support a creative, untested strategy: sugary drinks deliver empty calories, with a direct relationship to obesity, while portion sizes have grown exponentially. Society cannot know what works until commonsense ideas are tested." The soda portion limit is currently being decided by the New York State's highest court.

Gostin also singles out Bloomberg's program for monitoring diabetes. When the prevalence of diabetes in New York City nearly tripled in a decade, rising from 3.7 percent in 1994 to 9.2 percent in 2004, the city declared it an epidemic. In response, the city required laboratories to report blood sugar test results to the health department, which then informed treating physicians and patients with elevated blood sugar. "The program is one of the first uses of surveillance that not only tracks a chronic, noncommunicable disease but also links the data to concrete interventions," Gostin writes. "It bridges the historic divide between public health and medicine, thus offering pathways for future programs."

In addition, Gostin analyzes Bloomberg's policies for menu labeling, facilitating bicycle use, and increasing the number of pedestrian paths and parks. Gostin also offers point-by-point analysis of the critiques of Bloomberg and his policies, including charges of paternalism, assertions that the policies infringe upon corporate rights, and objections to his wielding of unilateral executive power

Regardless of the mixed success of the policies and the criticisms leveled at them, Gostin concludes that Bloomberg's approach to public health is not a passing fad. "It is rather a sober and necessary response to an epidemiological transition to life-style related diseases," he writes. "The public health community should take time to recognize and defend its championsand Mayor Bloomberg undoubtedly is among our most courageous and creative advocates for a healthier and safer population."


'/>"/>

Contact: Susan Gilbert
gilberts@thehastingscenter.org
845-424-4040 x244
The Hastings Center
Source:Eurekalert

Related biology news :

1. Tortoise and the hare: New drug stops rushing cancer cells, slow and steady healthy cells unharmed
2. Reproductive health providers should discuss environmental exposure risks with patients
3. Research on flavanols and procyanidins provides new insights into how these phytonutrients may positively impact human health
4. New antibiotic could make food safer and cows healthier
5. 2 servings of salmon a week is healthy for pregnant women and their babies
6. Why getting healthy can seem worse than getting sick
7. U-M Health and Retirement Study adds genetic data to NIH database
8. Improving equine health: Research studies vaccinations to protect newborn foals
9. New UH lecture series examines impact of science on health
10. Loss of predators in Northern Hemisphere affecting ecosystem health
11. Geographic information systems demonstrate links between health and location
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2017)... Feb. 2, 2017   TapImmune, Inc. ... company specializing in the development of innovative peptide ... of cancer and metastatic disease, announced today it ... manufacturing of a second clinical lot of TPIV ... receptor alpha. The manufactured vaccine product will be ...
(Date:2/1/2017)... IDTechEx Research, a leading provider of independent market research, business ... new report, Sensors for Robotics: Technologies, Markets and Forecasts 2017-2027 ... ... Revenues of ... for Robotics: Technologies, Markets and Forecasts 2017-2027: Machine vision, force sensing ...
(Date:1/26/2017)...  Crossmatch, a leading provider of security and identity ... combatting fraud, waste and abuse in assistance operations around ... on Disaster Relief conference in Panama City ... and foreign assistance organizations throughout Latin America ... a largely unacknowledged problem in the foreign assistance and ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... ... February 23, 2017 , ... The Greater Gift ... new partnership with Compass Research . GGI's mission is to advance global health ... a child in need in honor of each clinical trial volunteer. The vision of ...
(Date:2/23/2017)... and SAN FRANCISCO , ... privately-held regenerative medicine company, and Beyond Type 1, a ... type 1 diabetes, today announced a grant from Beyond ... functional cure for type 1 and other insulin-requiring diabetes.  ... has been developing innovative stem cell-derived cell replacement therapies ...
(Date:2/22/2017)... ... February 22, 2017 , ... Kernel , ... Research Systems, LLC (KRS) clinical development program. KRS is a neurotechnology spin-out ... research and clinical applications. The terms of the transaction were not disclosed. ...
(Date:2/22/2017)... 22, 2017 Scientists propose in Nature ... damage in Gaucher and maybe other lysosomal storage diseases ... costs than current therapies. An international research ... , which also included investigators from the University of ... data Feb. 22. The study was conducted in mouse ...
Breaking Biology Technology: